NDUFAB1 and neoplasm: Thus, adjuvant therapeutic strategies capable of controlling this tumor should be encouraged.<h4>Methods</h4>We analyzed seven fresh tumor specimens ACP from patients < 18 years of age using a chemoresistance platform (Bioverso Test, Ziel Biosciences, São Paulo, Brazil).